Stockscreener 앱 받기
6.08
7.80%
0.44
시장 영업 전:
6.18
0.10
+1.64%
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
Does Terns Pharmaceuticals Inc. show high probability of reboundFree Breakout Confirmation With Entry Tracker - Newser
Heatmap analysis for Terns Pharmaceuticals Inc. and competitorsSecure Trading Strategy Based on Technical Analysis - Newser
Is Terns Pharmaceuticals Inc. stock bottoming outProfitable Trading Blueprint with Entry Zones - Newser
Terns Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks
Custom strategy builders for tracking Terns Pharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser
Best data tools to analyze Terns Pharmaceuticals Inc. stockVolume Based Swing Signal Prediction Map - Newser
William Blair Has Positive Outlook of TERN FY2025 Earnings - Defense World
Will earnings trigger a reversal in Terns Pharmaceuticals Inc.Low Exposure Strategy with Sector Analysis - Newser
Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.AI Trend Detection for Entry Timing - Newser
What institutional flow reveals about Terns Pharmaceuticals Inc.Risk-Managed Strategy Based on Price Analysis - Newser
How Terns Pharmaceuticals Inc. stock performs during market volatilityFree Portfolio Diversification Stock Ideas - Newser
What makes Terns Pharmaceuticals Inc. stock price move sharplyAI-Based Stock Behavior Forecast Engine - Newser
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors - Benzinga
Terns Pharmaceuticals Beats Loss Projections And Ramps Up Drug Trials - Finimize
Terns Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Terns Pharmaceuticals: Earnings Beat and Strategic Pipeline Momentum Signal Long-Term Growth Potential - AInvest
Terns Pharma reports Q2 net loss - MarketScreener
Terns Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - The Manila Times
Terns Pharmaceuticals Inc. stock prediction for this weekFree Weekly Stock Opportunity Radar Scanner - Newser
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Biotech Terns Pharmaceuticals Appoints Chief People Officer, Awards Massive 500,000 Share Option Package - Stock Titan
Should I hold or sell Terns Pharmaceuticals Inc. stock in 2025Discover breakthrough stocks before the crowd - Jammu Links News
How strong is Terns Pharmaceuticals Inc. company’s balance sheetOutstanding capital growth - Jammu Links News
What is the risk reward ratio of investing in Terns Pharmaceuticals Inc. stockTurn volatility into profit opportunities - Jammu Links News
What drives Terns Pharmaceuticals Inc. stock priceAchieve consistent profits with expert advice - Jammu Links News
How does Terns Pharmaceuticals Inc. generate profit in a changing economyTake advantage of unprecedented market momentum - Jammu Links News
What analysts say about Terns Pharmaceuticals Inc. stockCapitalize on proven trading setups - Jammu Links News
What institutional investors are buying Terns Pharmaceuticals Inc. stockGain insights from top financial experts - Jammu Links News
Is Terns Pharmaceuticals Inc. stock overvalued or undervaluedHigh-yield capital appreciation - Jammu Links News
Terns Pharmaceuticals Inc. stock trend forecastMarket Correction Proof Stock Screening Analysis - newser.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
What are Terns Pharmaceuticals Inc. company’s key revenue driversSuperior stock growth - Jammu Links News
Terns Pharmaceuticals (TERN) to Release Quarterly Earnings on Monday - Defense World
Terns TERN 2025Q2 Earnings Preview Upside Potential with Improved EPS Forecast - AInvest
What catalysts could drive Terns Pharmaceuticals Inc. stock higher in 2025Wealth Building Planner With Proven Results - Jammu Links News
Terns Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should KnowEarly Breakout Tracker - beatles.ru
0.24%
3.39%
자본화:
|
볼륨(24시간):